Andrew C. Adams

Statistics

Publications

Citations

10.5K

H-Index

Active since

1962

Affiliations

Eli Lilly (United States)(Current)

Beth Israel Deaconess Medical Center

Harvard University

University of Nottingham

Queen's Medical Centre

Andrew C. Adams is an author at Eli Lilly (United States) specializing in life sciences, metabolic regulation, and fibroblast growth factor 21 signaling.

ORCID

Publications per year

1962–2023

Publications

Rapid, reversible activation of AgRP neurons drives feeding behavior in mice

Michael J. Krashes, Shuichi Koda, Chian-Ping Ye et al. · Journal of Clinical Investigation · 2011 · 1.6K citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen, Ajay Nirula, Barry N. Heller et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19

Robert Gottlieb, Ajay Nirula, Peter Chen et al. · JAMA · 2021 · 947 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +15

Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice

Mariela Jaskelioff, Florian L. Müller, Ji-Hye Paik et al. · Nature · 2010 · 835 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice

William L. Holland, Andrew C. Adams, Joseph T. Brozinick et al. · Cell Metabolism · 2013 · 531 citations · Full text

Life Sciences, Endocrinology, Physiology +14

1–5 of 58